Professor Glenn King has been working on animal venoms since 1996.He has extensive experience in the discovery, production, and structural and functional characterization of venom proteins, and is intimately aware of the issues surrounding their development as drugs and insecticides. In 2006, Professor King founded an agricultural biotechnology company, Vestaron Corporation, that is developing spider-venom peptides discovered in the lab as bioinsecticides.His current research is largely focussed on the development of venom peptides as analgesics for the treatment of chronic pain.
9 Ebooks bởi David E Thurston
Khondaker Miraz Rahman & David E Thurston: Small-molecule Transcription Factor Inhibitors in Oncology
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be ‘reprogrammed’, leading to apoptos …
PDF
Anh
DRM
€199.99
Glenn F. King: Venoms to Drugs
The pharmaceutical industry has become increasingly interested in biologics from animal venoms as a potential source for therapeutic agents in recent years, with a particularly emphasis on peptides. …
EPUB
Anh
DRM
€229.99
James D Adams & Eric J Lien: Traditional Chinese Medicine
Traditional Chinese medicine has a strong scientific basis, but the science of these important preparations is often rarely discussed. Western approaches often simplify traditional Chinese medicine t …
EPUB
Anh
DRM
€199.99
Khondaker Miraz Rahman & David E Thurston: Small-molecule Transcription Factor Inhibitors in Oncology
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be ‘reprogrammed’, leading to apoptos …
EPUB
Anh
DRM
€199.99
David E Thurston & Paul J M Jackson: Cytotoxic Payloads for Antibody–Drug Conjugates
Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadc …
EPUB
Anh
DRM
€239.99
Raphael Gorodetsky & Richard Schäfer: Stem Cell-Based Tissue Repair
The need for customized stem cell therapies for specific conditions will be a major issue in the coming decades. This unique book by experts in the field reviews the subject as it stands today. Its c …
PDF
Anh
DRM
€184.99
James D Adams & Eric J Lien: Traditional Chinese Medicine
Traditional Chinese medicine has a strong scientific basis, but the science of these important preparations is often rarely discussed. Western approaches often simplify traditional Chinese medicine t …
PDF
Anh
DRM
€199.99
Glenn F. King: Venoms to Drugs
The pharmaceutical industry has become increasingly interested in biologics from animal venoms as a potential source for therapeutic agents in recent years, with a particularly emphasis on peptides. …
PDF
Anh
DRM
€229.99
David E Thurston & Paul J M Jackson: Cytotoxic Payloads for AntibodyDrug Conjugates
Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadc …
PDF
Anh
DRM
€239.99